Invention Grant
- Patent Title: CTLA-4 antibody dosage escalation regimens
- Patent Title (中): CTLA-4抗体剂量升高方案
-
Application No.: US11567846Application Date: 2006-12-07
-
Publication No.: US08110194B2Publication Date: 2012-02-07
- Inventor: Geoffrey M. Nichol , Israel Lowy
- Applicant: Geoffrey M. Nichol , Israel Lowy
- Applicant Address: US NJ Princeton
- Assignee: Medarex, Inc.
- Current Assignee: Medarex, Inc.
- Current Assignee Address: US NJ Princeton
- Agency: Baker Botts L.L.P.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
A disease or condition, such as cancer or an infectious disease, can be treated in a patient by administering a CTLA-4 antibody in an escalating dosage regimen until a partial or complete response is elicited in the patient or a pre-determined maximum dosage is reached.
Public/Granted literature
- US20070160619A1 CTLA-4 Antibody Dosage Escalation Regimens Public/Granted day:2007-07-12
Information query
